Nearly one in ever five pediatric patients with cerebral palsy use the marijuana compound cannabidiol (CBD) to help combat symptoms of the ailment, according to a new study published in the journal Orthopedics.
For the study, researchers at Stanford University conducted a survey of caregivers who have children with cerebral palsy (CP) regarding their use of CBD products.
“Cannabidiol (CBD)-containing supplements are used by children with cerebral palsy (CP), but the prevalence and efficacy of their use have not been studied”, states the study. “We sought to describe CBD use patterns and perceived efficacy in the pediatric population with CP, evaluating any association between CBD use and health-related quality of life.”
Continue reading